Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Indometacin 10mg/5ml oral liquid
1001010K0AAAXAX
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 1 |
|
Indometacin 75mg modified-release tablets
1001010K0AAAJAJ
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 1 |
|
Industrial methylated spirit 70% / Glycerol 1% gel
1311010A0AAAKAK
|
Industrial methylated spirit | Alcohol | Skin | 1 |
|
Inhixa 300mg/3ml solution for injection multidose vials
0208010D0BCAHAH
|
Inhixa | Enoxaparin | Cardiovascular System | 1 |
|
Innovative Solutions Pure xanthan gum
0913461D0BCAAAB
|
Innovative specialist food replacer OTC/disc flour additives | Specialist food replacer OTC/disc flour additives (0913461) | Nutrition and Blood | 1 |
|
Insulin aspart biphasic 30/70 100units/ml inj 3ml cartridges
0601012W0AAAAAA
|
Insulin aspart biphasic | Biphasic insulin aspart | Endocrine System | 1 |
|
Insulin isoph biphas hum 25/75 100u/ml inj 3ml pf dispos dev
0601012D0AABWBW
|
Biphasic isophane insulin | Biphasic isophane insulin | Endocrine System | 1 |
|
Insulin isophane biphasic human 50/50 100u/ml inj 3ml cart
0601012D0AABUBU
|
Biphasic isophane insulin | Biphasic isophane insulin | Endocrine System | 1 |
|
Insulin lispro biphasic 50/50 100units/ml inj 3ml cartridges
0601012F0AAADAD
|
Insulin Lispro biphasic | Biphasic insulin lispro | Endocrine System | 1 |
|
Insulin soluble human 100units/ml inj 3ml cartridges
0601011N0AAAPAP
|
Insulin soluble | Soluble insulin (Neutral insulin) | Endocrine System | 1 |
|
Intraven sodium chloride 0.9% infusion 100ml bags
0902021S0BGADCJ
|
Intraven sodium chloride | Sodium chloride | Nutrition and Blood | 1 |
|
Intraven sodium chloride 0.9% infusion 500ml bags
0902021S0BGABAY
|
Intraven sodium chloride | Sodium chloride | Nutrition and Blood | 1 |
|
Iodine aqueous oral solution
0602020G0AAABAB
|
Iodine (Systemic) | Iodine | Endocrine System | 1 |
|
iQ Cath Easy hydrophilic catheter male 10Ch-18Ch
21020001284
|
iQ Cath Easy hydrophilic catheter male 10Ch-18Ch | Catheters | Appliances | 1 |
|
Iron sucrose 100mg/5ml solution for injection vials
0901012I0AAABAB
|
Iron sucrose | Iron sucrose | Nutrition and Blood | 1 |
|
Ironorm syrup
0901011C0BSABA0
|
Ironorm (Compound) | Compound iron preparations | Nutrition and Blood | 1 |
|
Isopto Alkaline 1% eye drops
1108010F0BBAAAC
|
Isopto Alkaline | Hypromellose | Eye | 1 |
|
Isosource Junior liquid
090402000BBLNA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | 1 |
|
Itraconazole 50mg/5ml oral liquid
0502010C0AAACAC
|
Itraconazole | Itraconazole | Infections | 1 |
|
Ivacaftor 150mg tablets
0307000S0AAAAAA
|
Ivacaftor | Ivacaftor | Respiratory System | 1 |
|
Jakavi 20mg tablets
0801050BIBBACAC
|
Jakavi | Ruxolitinib | Malignant Disease and Immunosuppression | 1 |
|
Jesacrin 750mg modified-release tablets
0601022B0BTAAAT
|
Jesacrin | Metformin hydrochloride | Endocrine System | 1 |
|
Jobskin Alleviant class 1 (18-21mmHg) thigh length closed toe with silicone top band
21270001201
|
Jobskin Alleviant class 1 (18-21mmHg) thigh length closed toe with silicone top band | Lymphoedema Garments | Appliances | 1 |
|
Jobskin MTM Premium behind knee lining for lymphoedema garment
21270001646
|
Jobskin MTM Premium behind knee lining for lymphoedema garment | Lymphoedema Garments | Appliances | 1 |
|
Jobskin MTM Premium class 1 (18-21mmHg) armsleeve
21270001560
|
Jobskin MTM Premium class 1 (18-21mmHg) armsleeve | Lymphoedema Garments | Appliances | 1 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.